Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
about
Therapy-Related Myeloid NeoplasmsThe clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogeneticsDouble inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression.Isochromosome 17q in Chronic Lymphocytic Leukemia.Molecular pathophysiology of myelodysplastic syndromes.An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview.Mutational spectrum defines primary and secondary myelofibrosis.A novel case of extreme thrombocytosis in acute myeloid leukemia associated with isochromosome 17q and copy neutral loss of heterozygosity.SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity.Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea.Isochromosome 17q10 associated with basophilia in primary myelofibrosis while with JAK2 inhibitor.Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.Correlation of myelodysplastic syndromes with i(17)(q10) andTP53andSETBP1mutationsAcute myeloid leukemia
P2860
Q26799786-94C4FD75-C67B-47D2-A018-B80A1693ED1AQ33407572-21865A04-FCA5-4D57-8795-5A6291FAC5B5Q34205736-57A1972E-2AD6-47ED-9024-4569EFC4A800Q35985807-58D531E7-5814-4763-B177-C1A8391619F2Q36366951-ABB9B005-7C29-45ED-A1EF-7E9569BC170BQ36445968-364E9B5D-34B8-4921-9270-AB44B3482E96Q36708989-5914FD9C-7711-4DBE-8D58-D19A9B333BBFQ37046592-63B0E995-65A4-49EE-9E2C-A8E189744AE7Q38248429-BC5B26B5-7D88-40E6-BE44-1D9C69934C59Q38415206-CDAAB8FD-284B-44A5-9188-2AB75C0FC545Q40607863-F18C77D7-5458-4AF1-A4C9-9D5A5815C2E2Q42285087-858B84F6-F9AE-4639-81C3-5483F4FD6769Q42551345-970A0686-C834-4B81-850F-F9096E5D5B3BQ43225081-0980FF7D-9F70-41A1-A3FD-9906A9B57E62Q43685807-957C37EE-FBA8-4E5F-9C0D-7365777AAE3DQ47157448-19B402D2-4A9A-4EBA-A9F1-A6D8D2360114Q48730157-616DA5AE-4D3D-4F73-A3F1-E1D81CDF97C2Q53298144-9B8C782F-94D2-4587-A9A8-2F43905D5FC4Q53534285-E3DAE493-252C-47CF-88D7-78FFF05679A9Q54982126-AFDBEE27-5801-4606-B65B-A76525263F45Q58074618-CE9945FC-125C-4509-9377-F745F27276AEQ58481761-E6252F6F-E81E-4172-BEFF-E7AB5A9C5E34
P2860
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@ast
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@en
type
label
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@ast
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@en
prefLabel
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@ast
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@en
P2093
P2860
P356
P1433
P1476
Myeloid neoplasms with isolate ...... formation, and wild-type TP53.
@en
P2093
Bedia Barkoh
C Cameron Yin
Carlos E Bueso-Ramos
Daniela Hoehn
L Jeffrey Medeiros
Saroj Vadhan-Raj
P2860
P304
P356
10.1002/CNCR.26537
P407
P577
2011-10-28T00:00:00Z